Loading organizations...
§ Private Profile · Epalinges, Vaud, Switzerland
Medical device, Dexter surgical robot for laparoscopic robotic surgery in hospitals: general surgery, gynecology, urology.
Based in Lausanne, Switzerland, Distalmotion is a medical device manufacturer that develops the Dexter surgical robot, a specialized laparoscopic robotic surgery system designed to integrate directly into existing sterile field workflows. The enterprise has scaled its operations to approximately 150 employees, and its primary hardware platform has been utilized in nearly 800 clinical cases across more than 35 different surgical procedures. In early 2026, the firm secured $150 million in venture funding to accelerate its ongoing European clinical expansion and pursue regulatory clearance from the FDA for United States commercial market entry. The organization's executive leadership and corporate governance currently include Chief Executive Officer Greg Roche, Chief Operating Officer Michael Friedrich, alongside board members Rick Anderson and Martin Dewhurst. Distalmotion was officially founded in 2012 as a commercial spin-off originating from the dedicated robotics laboratory at EPFL.
Distalmotion has raised $390.0M across 3 funding rounds.
Distalmotion has raised $390.0M in total across 3 funding rounds.
Distalmotion has raised $390.0M across 3 funding rounds. Most recently, it raised $150.0M Series G in November 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 28, 2025 | $150M Series G | Dana Hall | — | Announced |
| Apr 19, 2023 | $150M Series F | Rick Anderson | Dexter Angels | Announced |
| Jan 26, 2022 | $90M Series E | Rick Anderson | 415 Capital | Announced |
Distalmotion has raised $390.0M in total across 3 funding rounds.
Distalmotion's investors include Dana Hall, Rick Anderson, Dexter Angels, 415 Capital.